Guideline for Pharmaceutical Product & Location Master Data Template and Guidance

Authored on
July 21, 2021

The Guideline for Pharmaceutical Product and Location Master Data Sharing Template and Guidance is intended for use by ministries of health (MoHs) and/or national drug regulatory authorities (NDRAs). Its purpose is to support implementation of existing regulation and statutory instruments governing sharing of product and associated locations master data for pharmaceutical products authorized to be distributed in the market. A guideline for pharmaceutical products and location master data sharing should provide regulated marketing authorization holders (MAHs) or other relevant trading partners subject to an overarching regulation the information required to effectively comply. Where such instruments do not exist, the NDRA should determine the applicable country framework to enforce this document.


July 21, 2021